Epcoritamab-Bysp Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 4 mg/0.8 mL, 48 mg/0.8 mL
Reference Brands: EPKINLY (USA)
Category:
Oncology Cancer Care
Epcoritamab (brand name Epkinly) is a bispecific monoclonal antibody that binds to both CD3 on T-cells and CD20 on B-cells, redirecting T-cells to kill malignant B-cells. It is indicated for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after two or more lines of systemic therapy. Administered subcutaneously, Epkinly provides an off-the-shelf immunotherapy alternative to CAR-T treatments. The medicine is jointly developed and marketed by AbbVie and Genmab.
Epcoritamab-bysp is available in Injection
and strengths such as 4 mg/0.8 mL, 48 mg/0.8 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Epcoritamab-bysp is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Epcoritamab-bysp can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing